Showing results (741-750 of 810) with videos related to

Sort By:
Pageof 81
Hemasphere|September 21, 2023
High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLLPaul J Hengeveld, P Martijn Kolijn, Jeroen A A Demmers, et al.
Therapeutic Drug Monitoring|January 30, 2024
Predictive Performance of a Gentamicin Pharmacokinetic Model in Term Neonates with Perinatal Asphyxia Undergoing Controlled Therapeutic HypothermiaMarlotte A A van der Veer, Timo R de Haan, Linda G W Franken, et al.
Blood|July 28, 2018
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AMLMathijs A Sanders, Edward Chew, Christoffer Flensburg, et al.
BJS Open|June 29, 2018
Nationwide study of patients with head and neck paragangliomas carrying SDHB germline mutationsJ A Rijken, N D Niemeijer, C R Leemans, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 12, 2012
Resection of liver metastases in patients with breast cancer: survival and prognostic factorsG A M van Walsum, J A M de Ridder, C Verhoef, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2018
Evaluation of a System-Specific Function To Describe the Pharmacokinetics of Benzylpenicillin in Term Neonates Undergoing Moderate HypothermiaYuma A Bijleveld, Timo R de Haan, Johanna H van der Lee, et al.
British Journal of Clinical Pharmacology|January 15, 2016
Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermiaYuma A Bijleveld, Timo R de Haan, Hanneke J H van der Lee, et al.
The Lancet. Healthy Longevity|November 28, 2025
Understanding changes in complex care needs over time: key research insights into multimorbidity trajectoriesAmaia Calderón-Larrañaga, Elisa Fabbri, Ana Isabel González, et al.
British Journal of Clinical Pharmacology|March 7, 2024
Population pharmacokinetics of vancomycin in term neonates with perinatal asphyxia treated with therapeutic hypothermiaMarlotte A A van der Veer, Timo R de Haan, Linda G W Franken, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapyR van der Pas, C de Bruin, F W G Leebeek, et al.
Pageof 81